Clinical Trial Update: Effect of High-Dose Vitamin D on Bone Density in Osteogenesis Imperfecta [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating whether high-dose vitamin D improves bone density in individuals with Osteogenesis Imperfecta has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteogenesis Imperfecta

Drugs mentioned

• Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: Louis-Nicolas Veilleux Ph.D. | Conditions: Osteogenesis Imperfecta | Phase 4 | Status: COMPLETED